Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interaction.
about
Tailoring the Treatment of Melanoma: Implications for Personalized MedicineImmunocytokines and bispecific antibodies: two complementary strategies for the selective activation of immune cells at the tumor siteAdvances in lupus stemming from the parent-into-F1 modelExpression of a "self-"antigen by human tumor cells enhances tumor antigen-specific CD4(+) T-cell function.CTL-promoting effects of CD40 stimulation outweigh B cell-stimulatory effects resulting in B cell elimination and disease improvement in a murine model of lupus.IL-4 suppresses very late antigen-4 expression which is required for therapeutic Th1 T-cell trafficking into tumors.Anti-GD2 mAbs and next-generation mAb-based agents for cancer therapy.Rescue of CD8 T cell-mediated antimicrobial immunity with a nonspecific inflammatory stimulus.Systemically transplanted human gingiva-derived mesenchymal stem cells contributing to bone tissue regeneration.Agonistic anti-CD40 promotes early development and increases the incidence of severe thyroid epithelial cell hyperplasia (TEC H/P) in CD4-/- mice.
P2860
Q26775806-737E7795-EBCF-474D-8599-7007FB17B8E1Q28066935-0F7E2E27-094C-4A33-B47E-6D0DB80F1F62Q33903169-6662DDD5-2A97-4836-8EEF-ED434A3DA9D6Q36471604-18D5BA4E-788C-40E4-8DD2-C0CA016E2DBEQ37034711-C9749DAF-6B78-44E8-A1DC-E1D01B14C854Q37485130-883FABCC-B72E-4852-A783-D982CD734F96Q38916529-A195F912-B103-4C97-8340-BF3447ABBE81Q39740808-0DD0AE54-1951-48C2-A5FC-9D1741FF9008Q42053709-7BEC8533-A4CD-49DC-AED8-32964FADE7D7Q42054432-3729C427-DC4A-478B-B19D-ABBE9E6FFA05
P2860
Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interaction.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Melanoma immunotherapy by targeted IL-2 depends on CD4
@nl
Melanoma immunotherapy by targ ...... ted by CD40/CD40L interaction.
@ast
Melanoma immunotherapy by targ ...... ted by CD40/CD40L interaction.
@en
type
label
Melanoma immunotherapy by targeted IL-2 depends on CD4
@nl
Melanoma immunotherapy by targ ...... ted by CD40/CD40L interaction.
@ast
Melanoma immunotherapy by targ ...... ted by CD40/CD40L interaction.
@en
prefLabel
Melanoma immunotherapy by targeted IL-2 depends on CD4
@nl
Melanoma immunotherapy by targ ...... ted by CD40/CD40L interaction.
@ast
Melanoma immunotherapy by targ ...... ted by CD40/CD40L interaction.
@en
P2093
P2860
P356
P1476
Melanoma immunotherapy by targ ...... ted by CD40/CD40L interaction.
@en
P2093
R A Reisfeld
S D Gillies
S P Schoenberger
P2860
P304
P356
10.1172/JCI9177
P407
P577
2000-06-01T00:00:00Z